| Literature DB >> 33296059 |
Atsushi Yamamoto1, Shinji Furuya2, Koichi Takiguchi1, Makoto Sudo1, Katsutoshi Shoda1, Hidenori Akaike1, Naohiro Hosomura1, Yoshihiko Kawaguchi1, Hidetake Amemiya1, Hiromichi Kawaida1, Hiroshi Kono1, Daisuke Ichikawa1.
Abstract
BACKGROUND: Nodular fasciitis (NF) is a type of rare and rapidly growing tumor that affects the muscular fascial layers. Due to its locally aggressive nature and rapid growth, NF can be mistaken as a malignant process on either clinical or histological grounds. CASEEntities:
Keywords: Nodular fasciitis; Port site after robotic surgery; Rectal cancer
Year: 2020 PMID: 33296059 PMCID: PMC7726077 DOI: 10.1186/s40792-020-01049-8
Source DB: PubMed Journal: Surg Case Rep ISSN: 2198-7793
Fig. 1Abdominal CT scan reveals a tumor measuring 45 mm in a diameter at port site in right abdominal wall after 19 months later from the rectal cancer operation (a). Abdominal MRI, the mass was hypo-intense to muscle on T1 imaging (b), and hyper-intense on T2 (c). Some restricted diffusion was seen around the lesion (d)
Fig. 2Preoperative findings (a). There was no overlying skin changes, the swelling was firm and was not tethered to overlying skin in the upper right abdominal wall. There was the defect of abdominal wall after resection of tumor (b). The defect area was covered with mesh as artificial fascia and the right fascia lata with pedicled flap (c, d). The abdominal and the femoral scar of operation after 3 months (e, f)
Fig. 3Macroscopic findings of the resected tumor (a). Excised specimen (b). Well circumscribed solid lesion approximately 40 mm in maximum diameter
Fig. 4Haematoxylin and eosin stain demonstrating loosely arranged bundles of spindled fibroblastic/myofibroblastic cells without significant atypia, scattered small-sized thin-walled vessels (× 4) (a), and extravasated erythrocytes intermingled with spindled myofibroblastic/fibloblastic cells (× 20) (b)
Fig. 5Immunohistochemistry demonstrating positive staining for smooth muscle actin (α-SMA). (× 200) (a). Immunohistochemistry demonstrating positive staining at low power (3~5%) for Ki67 (× 200) (b). Immunohistochemistry demonstrating negative staining for MUC4 (× 200) (c). Immunohistochemistry demonstrating negative staining in the nucleus for β-catenin (× 200) (d)